Evaluation of two distinctive beta-carbolines on serotonin binding in human platelets.
D L Taylor, W Tansey, J M Cook, B T Ho
Index: Res. Commun. Chem. Pathol. Pharmacol. 47(1) , 133-6, (1985)
Full Text: HTML
Abstract
6-MeOTHBC binds to both high and low affinity receptors in human platelets. The beta-carboline is less active than chlorimipramine at the low affinity site, and it is weaker than methysergide, a known 5-HT antagonist, at the high affinity site. The other beta-carboline, B-CCE, is not active at either receptor in platelets. The data supports the view that platelets could be used as a limited model for studying 5-HT-ergic neurons.
Related Compounds
Related Articles:
2010-08-01
[J. Pineal Res. 49(1) , 78-85, (2010)]
2009-03-01
[Drug Metab. Dispos. 37(3) , 443-6, (2009)]
2003-01-01
[J. Trace Elem. Med. Biol. 17(1) , 39-44, (2003)]
2000-11-10
[Neurosci. Lett. 294(1) , 1-4, (2000)]
2007-10-01
[J. Enzyme Inhib. Med. Chem. 22(5) , 556-62, (2007)]